In 1973, Eugene Corasanti in Utica, New York founded Consolidated Medical Equipment, Inc. The first product was the disposable ECG monitoring electrode. The disposable electrode market was newly emerging at a time in the history of U.S. healthcare when disposable products were rapidly gaining acceptance.

As CONMED’s business grew, so did its product line. CONMED expanded into the electrosurgery market with a line of disposable grounding pads and pencils. In 1987, the company went public issuing approximately 4 million shares. In 1989, CONMED completed its first major acquisition. It purchased Aspen Labs from Bristol Myers Squibb with this transaction making the company a very strong competitor in the electrosurgery market. In the 1990’s, CONMED acquired several competitive companies that were producing ECG electrodes and electrosurgery products. In 1997, CONMED completed the acquisition of Linvatec, which made the company the number two worldwide producer of arthroscopy products and orthopaedic powered surgical instruments. In 2004, CONMED acquired the majority of the Endoscopic Technologies business from C.R. Bard accelerating its penetration into the Gastroenerology and Pulmonology markets.

Today, CONMED presently manufacturers thousands of products in eight different areas: Arthroscopy, Electrosurgery, Endoscopy, Endoscopic Technologies, EndoSurgery, Integrated Systems, Patient Care and Powered Surgical Instruments. We offer innovation and value added customer service across all of our product lines while holding the number 1 or number 2-market share position in the majority of our product line areas.

With eleven manufacturing facilities, 3100 employees and worldwide distribution, CONMED continues to uphold its mission after 30 years of existence. We continue to strive to improve the quality of healthcare by designing, producing and marketing innovative, high-quality products.